Clinical Trial Update: Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing semaglutide and dapagliflozin in type 2 diabetes patients with different pathophysiology; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• semaglutide (semaglutide)

Snippet

Sponsor: Region Skane | Conditions: Type2 Diabetes | Phase 2 | Status: ACTIVE_NOT_RECRUITING